Molina Healthcare, Inc. (NYSE:MOH) Q3 2023 Earnings Conference Call October 26, 2023 8:00 AM ET
Company Participants
Joe Krocheski – Senior Vice President-Investor Relations
Joe Zubretsky – President and Chief Executive Officer
Mark Keim – Chief Financial Officer
Conference Call Participants
Josh Raskin – Nephron Research
Kevin Fischbeck – Bank of America
Nathan Rich – Goldman Sachs
Justin Lake – Wolfe Research
Calvin Sternick – JPMorgan
Stephen Baxter – Wells Fargo
Scott Fidel – Stephens
A.J. Rice – UBS
George Hill – Deutsche Bank
Gary Taylor – Cowen
Sarah James – Cantor Fitzgerald
Operator
Good morning, and welcome to the Molina Healthcare Third Quarter 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded.
I would now like to turn the conference over to Joe Krocheski, Senior Vice President of Investor Relations. Please go ahead.
Joe Krocheski
Good morning, and welcome to Molina Healthcare’s third quarter 2023 earnings call. Joining me today are Molina’s President and CEO, Joe Zubretsky; and our CFO, Mark Keim. A press release announcing our third quarter earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release.
For those of you who listen to the rebroadcast of this presentation, we remind you that all of the remarks made are as of today, Thursday, October 26, 2023, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in our third quarter 2023 earnings release.
During the call, we will be making certain forward-looking statements including, but not limited to, statements regarding our 2023 guidance, Medicaid redeterminations, our recent RFP awards and related revenue growth, our 2024 outlook, our recent acquisitions and M&A activity, our long-term growth strategy and our embedded earnings power and margins. Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties. That could cause our actual results to differ materially from our current expectations.
We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions.